Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Ambipar buys Witt O’Briens for $161.5M, SPAC winter spreads to Middle East with two deals delayed, and Wag! partners with Babylist
Brazil’s Ambipar buys Witt O’Briens in $161.5 mln deal
Brazilian environmental services provider Ambipar said on Wednesday it bought Witt O’Briens for an enterprise value of $161.5 million, pushing ahead with its global expansion.
The deal, made through its subsidiary Ambipar Response, marks the company’s entry into Asia and Oceania markets and strengthens its presence in the continents where it already operates, Ambipar said in a securities filing.
SPAC Winter Spreads to Middle East With Two Deals Delayed
Concerns over the blank-check industry are spreading to the Middle East, dealing a blow to the region’s SPAC market that barely got off the ground.
Babylist and Wag! Join Forces To Help Pet Parents Welcome Baby Home
Babylist, the leading vertical marketplace and commerce destination for baby, and Wag! (Nasdaq: PET), a platform for busy pet parents, offering access to five-star dog walking, pet sitting, expert pet advice, wellness plans, and one-on-one training from a community of local pet caregivers, are helping new parents make the transition of bringing home a new baby a little easier.
READLevere SPAC’s Finance Chief Steps Down
Levere Holdings Corp. (NASDAQ:LVRA) said Tuesday that Stefan Krause, its chief financial officer and chief investment officer, intends to resign immediately.
The SPAC disclosed in a securities filing that Mr. Krause had given notice of his plans, and that the departure “was not a result of any disagreement with the company on any matter relating to its operations or its accounting or financial policies or procedures.”
READLanzaTech CEO Highlights Company Role as a Synthetic Biology Leader at White House Event Celebrating Biotechnology
LanzaTech NZ, Inc., an innovative Carbon Capture and Transformation company that transforms waste carbon into materials such as sustainable fuels, fabrics, packaging and other products that people use in their daily lives, today announced that Dr. Jennifer Holmgren, CEO of LanzaTech participated in the Summit on Biotechnology & Biomanufacturing for the American Bioeconomy today at The White House.
As previously announced LanzaTech has entered into a merger agreement for a business combination transaction with AMCI Acquisition Corp. II (Nasdaq: AMCI).
READ
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...
Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...
At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...